Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 12:04 PM
Ignite Modification Date:
2025-12-24 @ 12:04 PM
NCT ID:
NCT01257061
Brief Summary:
Atopic dermatitis is a recurrent pruritic skin disorder which has a significant morbidity and impaired quality of life due specially pruritus and physical visible skin lesions. The propose of this trial is evaluate the effectiveness of clemastine fumarate 1, 0 mg/g + dexamethasone 0, 5 mg/g compared to dexchlorpheniramine maleate 10 mg/g in eczema treatment.
Detailed Description:
Study design:
• Double blinded, superiority, prospective parallel-group, intend to treat trial.
Study design:
* Experiment duration: 22 days
* 2 visits (days 1,7,15 and 22)
* Reducing Eczema Area and severity index evaluation
* Adverse events evaluation
Study:
NCT01257061
Study Brief:
Protocol Section:
NCT01257061